Dr. Raed H. Abdelhadi, Cardiac Electrophysiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, reviews the background for the Riata ICD recall and the available data on the Riata ICD lead, explains the preliminary resul

Decongestive Strategies in Acute Heart Failure

Jan 16th, 2012

Dr. Steven R. Goldsmith, Professor of Medicine at the University of Minnesota, Director of the Heart Failure Program at Hennepin County Medical Center, and Director of the Minnesota Heart Failure Consortium, explains the importance of congesti

Atrial Fibrillation: New Agents for Stroke Prevention

Dec 19th, 2011

Dr. R. Jeffrey Westcott, Medical Director at the Cardiac Cath Lab at the Swedish Heart and Vascular Institute, discusses the pharmacology of the new oral direct thrombin and Xa inhibitors, evaluates what patients are more likely to experience

TCT/AHA Highlights: Platelets and Stem Cells

Nov 28th, 2011

Dr. Timothy Henry, Director of Research at the Minneapolis Heart Institute Foundation, and Dr. Jay Traverse, Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, review the results of the LateTIME,

Update in Preventive Cardiology 2011

Nov 21st, 2011

Dr. Thomas Knickelbine, Director of Preventive Cardiology at the Minneapolis Heart Institute at Abbott Northwestern Hospital discusses US population risk factors, explains how to approach patients with statin intolerance, describes the current

AHA Abstract Presentations

Oct 31st, 2011

Acute Aortic Intramural Hematoma: an analysis from the International Registry of Acute Aortic Dissection - Presented by Dr. Kevin M. HarrisCircadian Dependence of Infarct Size and Left-Ventricular Function Following ST-Elevation Myocardial I

Critical Limb Ischemia: Is there a role for drug eluting stents in the periphery?

Oct 24th, 2011

Dr. Steve Levin, Vascular Fellow at the University of Minnesota, defines critical limb ischemia, identifies the evolving role of drug eluting stents in the treatment of peripheral arterial disease and compares how drug eluting stents have perf

Repairing Valves: Why and Why Not?

Oct 17th, 2011

Dr. Benjamin Sun, Chair of Cardiac, Thoracic and Transplant Surgery at the Minneapolis Heart Institute at Abbott Northwestern Hospital, identifies which valves can be repaired, explains why we don't repair valves more frequently and describes

Cardiac Resynchronization Therapy: Developing a Center of Excellence

Oct 3rd, 2011

Dr. Alan J. Bank, Medical Director of Research at United Heart andVascular Clinic, andAssociate Professor of Cardiology at the University ofMinnesota, describes the components of a CRT Centerof Excellence, explains the mechanisms o

A Serious Complication of a Common Vascular Practice

Sep 26th, 2011

Dr. Nedaa Skeik, Vascular Medicine Consultant at the Minneapolis HeartInstitute® atAbbott Northwestern Hospital, explains different treatment modalitiesfor deep vein thrombosis (DVT), describes the history of inferior venacava

Sudden Death, Risk Stratification and Prevention in Hypertrophic Cardiomyopathy

Sep 19th, 2011

Dr. Barry J. Maron, Director of the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute at Abbott-Northwestern Hospital looks explains how to risk stratify hypertrophic cardiomyopathy (HCM) patients and describes the role of

Pacing the Heart: What side are you on?

Sep 12th, 2011

Senior Consulting Cardiologist at the Minneapolis Heart Institute at Abbott-Northwestern Hospital, Dr. Robert Hauser, summarizes pacinghemodynamics, describes thevalue of cardiac synchronization, and explains ICDreliability and patient long

Rate